Have your own idea? Try our Stock Screener
Samsung BiologicsLtd is up 3.2%, leading the way for the Healthcare industry, which has gained 3.8%. During this same period, the HLB underperformed, falling 5.4%. This takes the industry's 12 month performance to a gain of 26%. Looking forward, earnings are forecast to grow by 47% annually.
Has the South Korean Healthcare Sector valuation changed over the past few years?
Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
---|---|---|---|---|---|---|
Tue, 11 Feb 2025 | ₩280.4t | ₩54.6t | ₩831.2b | 15.5x | 337.4x | 5.1x |
Thu, 09 Jan 2025 | ₩268.7t | ₩54.5t | ₩828.4b | 14.3x | 324.4x | 4.9x |
Sat, 07 Dec 2024 | ₩246.8t | ₩54.4t | ₩787.5b | 13.5x | 313.4x | 4.5x |
Mon, 04 Nov 2024 | ₩264.3t | ₩53.3t | ₩857.9b | 15.6x | 308.1x | 5x |
Wed, 02 Oct 2024 | ₩266.5t | ₩53.3t | ₩838.0b | 17.2x | 318x | 5x |
Fri, 30 Aug 2024 | ₩266.3t | ₩53.3t | ₩1.0t | 16x | 257.7x | 5x |
Sun, 28 Jul 2024 | ₩255.6t | ₩52.3t | ₩750.8b | 16.6x | 340.4x | 4.9x |
Tue, 25 Jun 2024 | ₩227.3t | ₩52.7t | ₩742.9b | 16.1x | 305.9x | 4.3x |
Thu, 23 May 2024 | ₩226.5t | ₩52.4t | ₩752.5b | 18.1x | 301x | 4.3x |
Sat, 20 Apr 2024 | ₩229.0t | ₩52.3t | ₩538.5b | 17.5x | 425.2x | 4.4x |
Mon, 18 Mar 2024 | ₩237.9t | ₩52.2t | ₩60.1b | 20.8x | 3956.6x | 4.6x |
Wed, 14 Feb 2024 | ₩226.5t | ₩52.0t | -₩55,498,881,746.00 | 21x | -4080.4x | 4.4x |
Fri, 12 Jan 2024 | ₩230.3t | ₩56.1t | ₩268.5b | 23.5x | 857.8x | 4.1x |
Sun, 10 Dec 2023 | ₩211.4t | ₩56.1t | ₩284.3b | 22x | 743.5x | 3.8x |
Tue, 07 Nov 2023 | ₩208.4t | ₩56.0t | ₩1.0t | 18.9x | 203.3x | 3.7x |
Thu, 05 Oct 2023 | ₩205.1t | ₩56.0t | ₩1.0t | 18.3x | 200.4x | 3.7x |
Sat, 02 Sep 2023 | ₩211.0t | ₩56.0t | ₩932.5b | 19.9x | 226.2x | 3.8x |
Mon, 31 Jul 2023 | ₩208.2t | ₩56.1t | ₩2.1t | 20.6x | 99.6x | 3.7x |
Wed, 28 Jun 2023 | ₩207.6t | ₩56.3t | ₩2.1t | 20.9x | 98.5x | 3.7x |
Fri, 26 May 2023 | ₩219.0t | ₩56.9t | ₩2.5t | 21.3x | 87.7x | 3.9x |
Sun, 23 Apr 2023 | ₩213.6t | ₩58.4t | ₩3.2t | 20.6x | 65.7x | 3.7x |
Tue, 21 Mar 2023 | ₩206.8t | ₩58.0t | ₩4.3t | 19.5x | 48.4x | 3.6x |
Thu, 16 Feb 2023 | ₩202.8t | ₩57.8t | ₩4.6t | 18.3x | 44x | 3.5x |
Sat, 14 Jan 2023 | ₩206.5t | ₩58.0t | ₩4.4t | 16.5x | 47.2x | 3.6x |
Mon, 12 Dec 2022 | ₩209.7t | ₩57.5t | ₩3.9t | 16.6x | 54x | 3.6x |
Wed, 09 Nov 2022 | ₩208.2t | ₩55.9t | ₩4.0t | 15.4x | 51.8x | 3.7x |
Fri, 07 Oct 2022 | ₩194.7t | ₩55.7t | ₩4.1t | 16.1x | 47.3x | 3.5x |
Sun, 04 Sep 2022 | ₩216.3t | ₩56.0t | ₩4.2t | 17.8x | 51.3x | 3.9x |
Tue, 02 Aug 2022 | ₩226.6t | ₩54.2t | ₩3.9t | 19.9x | 58.3x | 4.2x |
Thu, 30 Jun 2022 | ₩208.2t | ₩54.2t | ₩3.9t | 18.6x | 53.5x | 3.8x |
Sat, 28 May 2022 | ₩223.9t | ₩53.0t | ₩4.0t | 22.1x | 56.4x | 4.2x |
Mon, 25 Apr 2022 | ₩222.9t | ₩51.0t | ₩4.0t | 22.5x | 56.1x | 4.4x |
Wed, 23 Mar 2022 | ₩233.7t | ₩50.5t | ₩4.5t | 23x | 52.3x | 4.6x |
Fri, 18 Feb 2022 | ₩217.9t | ₩49.0t | ₩4.3t | 21.3x | 50.4x | 4.4x |
50.4x
Which industries have driven the changes within the South Korean Healthcare sector?
KR Market | 3.43% | |
Healthcare | 4.88% | |
Healthtech | 9.61% | |
Pharma | 8.70% | |
Biotech | 5.74% | |
Life Sciences | 3.48% | |
Healthcare Services | 1.51% | |
Medical Equipment | -0.95% |
Which companies have driven the market over the last 7 days?
Company | Last Price | 7D | 1Y | Valuation | |
---|---|---|---|---|---|
A207940 Samsung BiologicsLtd | ₩1.17m | 9.5% +₩7.3t | 40.1% | PE79.4x | |
A326030 SK Biopharmaceuticals | ₩126.00k | 18.6% +₩1.6t | 45.2% | PE172x | |
A000100 Yuhan | ₩135.70k | 6.3% +₩607.5b | 114.0% | PE61.4x | |
A068270 Celltrion | ₩179.70k | 1.3% +₩487.9b | 0.6% | PE203.7x | |
A000250 Sam Chun Dang Pharm | ₩182.70k | 10.1% +₩388.4b | 165.6% | PE831.5x |